Tag Archives: licensing

Exclusive Licenses Do Not Discourage Follow On Research

medical_research_thumb

A recent study presented at the Patent Statistics for Decision Makers Conference organized at the United States Patent Office questions the logic behind a nonexclusive license preference often found in U.S. government technology transfer policy. In “The Role of Exclusive Licensing in Follow-on Research of Academic Patented Inventions” presentation the authors demonstrate that, contrary to the belief by some, exclusive licensing does not impede future research. The authors ask two questions.  First, does exclusive licensing affect licensee follow-on research?  Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

University Licensing Survey 2010 – AUTM

AUTM is set to release their AUTM Licensing Activity Survey Summary: FY 2010 in the fall of this year for both the U.S. and Canada.  AUTM issued a AUTM 2010 survey highlights to wet the appetite. Highlights: -The number of startups formed increased 10.6%.  651 startup companies formed of which 498 had their primary place of business in the licensing institution’s home state. -Number of licenses/options executed to startups increased 14%.  4,284 licenses executed and Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Bayh Dole Act a Failure? Part II: The Comments

By Guest Joseph Allen Yesterday we posted the reply of Robin Rasor, President of the Assn of University Technology Managers, to a Washington Post opinion piece by Vivek Wadhwa asserting that the university/industry technology transfer model established under the Bayh-Dole Act had failed and should be replaced.  The article set off a series of comments, the most interesting of which occurred when Mr Wadhwa challenged Rasor to document the statistics she used asserting the Bayh-Dole Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Joint Statement of BIO, AAU, ACE, APLU, AUTM and COGR

Earlier today, the United States Supreme Court issued its opinion in the appeal of Stanford University against Roche Diagnostics. This case is of significant interest to the Biotechnology Industry Organization (BIO), Association of American Universities (AAU), American Council on Education (ACE), Association of Public and Land-grant Universities (APLU), Association of University Technology Managers (AUTM), and Council on Governmental Relations (COGR) because of its potential impact on university technology transfer, on development and commercialization of university-generated Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , ,

GAO Report on Bayh-Dole: Leverage to Promote Commercialization of Federally-Funded Inventions

The General Accountability Office submitted its report to Congress today on the administration of the regulations found under the Bayh-Dole Act, the foundation of all federally-funded research in the United States and one of the key factors in the creation (and boom) of biotechnology as both a research field and industry in the 1980s. A little background on Bayh-Dole: Technological innovation is widely seen as responsible for much of the economic growth and increased standard Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,